Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Natalia Bujko-Wasiak
Institution:
University of Zielona Góra
Observed institution:
University of Zielona Góra
ORCID:
0009-0006-7358-5128
Observed ORCID:
0009-0006-7358-5128
OpenAlex ID:
A5107586337
Acute promyelocytic leukemia in patient with chronic myeloid leukemia treated with tyrosine kinase inhibitors
2024
·
Agnieszka Brzozowska
, Natalia Bujko-Wasiak
, et al.
·
Acta Haematologica Polonica
·
1
PDF
Moderate hemophilia C in pregnancy: a rare case of transfusion-related complications and life-saving off-label use of recombinant factor VIIa
2026
·
Agnieszka Ewa Brzozowska
, Natalia Bujko-Wasiak
, et al.
·
Hematology in Clinical Practice
PDF
Secondary cancers in breast cancer survivors. A two-centre study
2025
·
Mateusz Wichtowski
, Paulina Gibowska-Maruniak
, et al.
·
Archives of Medical Science
PDF
Eltrombopag jako potencjalna opcja terapeutyczna w leczeniu opornej małopłytkowości immunologicznej — opis przypadku
2025
·
Natalia Bujko-Wasiak
, Katarzyna Brzeźniakiewicz-Janus
·
Hematologia — Edukacja
Interleukin-6 as the preferred prognostic factor in infection-complicated acute myeloid leukemia
2025
·
Natalia Bujko-Wasiak
, Aleksandra Kaźmierczak
, et al.
·
Współczesna Onkologia
PDF
The Experience of Commercially Available CPX-351 Use As First-Line Treatment for Patients with Acute Myeloid Leukemia - a Report of Polish Adult Leukemia Group (PALG)
2024
·
Agnieszka Pluta
, Olga Racinska
, et al.
·
Blood
PDF
Succesful CPX-351 treatment of seminoma therapy-related acute myeloid leukemia in a patient with Klinefelter syndrome
2024
·
Natalia Bujko-Wasiak
, Wiesław Wiktor Jędrzejczak
, et al.
·
Acta Haematologica Polonica
PDF
Show more works
View as search
Works count:
7
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type